JBIO — Jade Biosciences, Inc.

JBIOJade Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · jadebiosciences.com

19.14USD-8.97%Mkt Cap: 916.86M USDP/E: —Last update: 2026-06-01

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to bl…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap916.86M USD

Enterprise Value728.09M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-127.41M USD

Revenue/Share—

Last Price19.14 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees55

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B3.50

EPS (TTM)-2.63

EPS (Forward)—

52W Range

6.56559% of range28.00

52W High28.00 USD

52W Low6.565 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-38.32%

ROA-36.43%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-94.69M USD

CapEx (TTM)196.00K USD

FCF Margin—

FCF Yield—

Net Debt-310.45M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.00

Current Ratio14.29

Quick Ratio13.96

Book Value/Sh6.008 USD

Cash/Share6.307 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateApr 28, 2025

Splits

Last Split1:35

Split DateApr 29, 2025

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)36.29 USD

Target Range24.00 USD – 45.00 USD

# Analysts7

Ownership

Shares Out.49.36M

Float32.74M

Insiders1.12%

Institutions101.31%

Short Interest

Short Ratio5.6d

Short % Float9.01%

Short % Out.6.88%

Shares Short3.40M

Short (prev mo.)3.06M

Technical

SMA 5020.55 (-6.9%)

SMA 20013.96 (+37.1%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)615.80K

Avg Vol (10d)491.50K

Technical Indicators

RSI (14)42.4

MACD-0.1032

MACD Signal0.4832

MACD Hist.-0.5863

BB Upper26.64 USD

BB Middle23.50 USD

BB Lower20.35 USD

BB Width26.78%

ATR (14)1.672 USD

Vol Ratio (20d)0.76x